SciBase Announces Additional Order From Castle Biosciences Valued At About $0.6M For Nevisense Go Devices And Electrodes To Accelerate Ongoing Atopic Dermatitis Study, Prepare Second Study; Deliveries Expected To Begin Q4 2026

Loading news article.

SciBase Announces Additional Order From Castle Biosciences Valued At About $0.6M For Nevisense Go Devices And Electrodes To Accelerate Ongoing Atopic Dermatitis Study, Prepare Second Study; Deliveries Expected To Begin Q4 2026 | WAPE

SciBase Announces Additional Order From Castle Biosciences Valued At About $0.6M For Nevisense Go Devices And Electrodes To Accelerate Ongoing Atopic Dermatitis Study, Prepare Second Study; Deliveries Expected To Begin Q4 2026

Article summary

Related companies

Comments —